Correction to Congressional Hearing Transcript on Purdue Pharma
January 1, 2022
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
This document updates the official public record of a congressional investigation into the opioid crisis, ensuring the accuracy of testimony provided by a Purdue Pharma representative.
Potentially affected actors named in the source documents. Mention is not a position.
Dr. Landau
The correction modifies the official record of his testimony provided to Congress.
House Committee on Oversight and Reform
The committee is responsible for maintaining the accuracy of its hearing transcripts.
Last recorded activity January 1, 2022.
Next step not available in the current record.
Summary
Key Facts
- The document serves as an official correction (Errata II) to the transcript of the December 17, 2020, House Oversight and Reform Committee hearing.
- The correction modifies the transcript on page 27 regarding an exchange between Dr. Landau and Representative Krishnamoorthi.
- The corrected text clarifies that Dr. Landau stated a specific slide was 'material in preparation for a meeting' rather than a final slide presented at the hearing.
- Dr. Landau explicitly denied the implication that he did not feel responsible for the materials discussed.
Why It Matters
This document updates the official public record of a congressional investigation into the opioid crisis, ensuring the accuracy of testimony provided by a Purdue Pharma representative.
Frequently Asked Questions
What is an 'errata' document?
Why was this correction issued?
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Transcript Accuracy
The document highlights the process of amending official congressional records to ensure testimony is accurately captured.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance20How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz5Current news / social attention level
Publisher tools